Assessment of implementation of GMP rules requirements at pharmaceutical drug production enterprises in Kyrgyz Republic

As everyone knows, since May 29, 2014, the Kyrgyz Republic has been a member of the Eurasian Economic Union. With its accession to the EAEU, the Kyrgyz Republic joined international treaties concluded by the EAEU member states, which were harmonized with each other and, together with other agreements, uniform rules for the pharmaceutical drugs production were adopted. It should be noted that according to the bill “On the circulation of pharmaceutical drugs”, in accordance with the provisions of the acts of the EAEU, until 2026, all entities engaged in the pharmaceutical drugs production must implement the appropriate GMP standards, which means a complete transition in the sphere of circulation of pharmaceutical drugs from the concept of “quality control” to concept of “quality assurance”.